Evoke Pharma, Inc. - Common Shares (EVOK) Institutional Ownership

CUSIP: 30049G203

13F Institutional Holders and Ownership History from Q2 2022 to Q3 2024

Type / Class
Equity / Common Shares
Symbol
EVOK on Nasdaq
Shares outstanding
1,582,162
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 30049G203?
CUSIP 30049G203 identifies EVOK - Evoke Pharma, Inc. - Common Shares in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of Evoke Pharma, Inc. - Common Shares (EVOK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 16% $101,856 254,639 Nantahala Capital Management, LLC 03 Feb 2025
Bleichroeder LP 10% 0% $63,223 158,058 -81% Bleichroeder LP 24 Mar 2025

Institutional Holders of Evoke Pharma, Inc. - Common Shares (EVOK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$1,666,575 0
2024 Q2 3,151,890 $1,667,349 -$8,058 $0.53 15
2024 Q1 3,163,387 $1,929,665 +$1,887,966 $0.61 14
2023 Q4 68,360 $71,786 +$1,253 $1.05 9
2023 Q3 67,157 $92,405 +$10,966 $1.38 9
2023 Q2 59,166 $97,415 -$18,661 $1.65 9
2023 Q1 68,914 $131,127 +$15,393 $1.90 11
2022 Q4 60,640 $161,234 -$4,397 $2.68 10
2022 Q3 62,420 $117,009 -$16,143 $1.87 7
2022 Q2 70,180 $228,016 +$228,016 $3.26 8